Valuation : Protia Inc.

Market Cap 66.72B 49.79M 42.84M 40.34M 36.76M 68.77M 4.74B 69.04M 478M 185M 2.41B 187M 183M 7.65B P/E 2024
14.5x
P/E 2025 18x
Enterprise Value 53.34B 39.8M 34.25M 32.25M 29.38M 54.98M 3.79B 55.2M 382M 148M 1.93B 149M 146M 6.11B EV / Sales 2024
2.1x
EV / Sales 2025 4.43x
Free-Float
57.15%
Yield 2024 *
-
Yield 2025 -
1 day+2.99%
1 week-1.90%
Current month-3.18%
1 month+1.37%
3 months+27.65%
6 months+9.30%
Current year-17.15%
1 week 4,950
Extreme 4950
5,230
1 month 4,650
Extreme 4650
5,470
Current year 3,680
Extreme 3680
6,240
1 year 3,680
Extreme 3680
6,890
3 years 2,430
Extreme 2430
6,890
5 years 2,430
Extreme 2430
8,440
10 years 2,430
Extreme 2430
17,350
Manager TitleAgeSince
Chief Executive Officer 65 31/05/2010
Corporate Officer/Principal 61 02/06/2022
Sales & Marketing 69 -
Director TitleAgeSince
Director/Board Member 65 31/05/2010
Director/Board Member 68 23/10/2020
Director/Board Member 61 02/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
+2.99%-1.90%-1.52%+36.77% 49.69M
-0.88%-1.06%+181.64%+377.45% 21.84B
+0.56%-5.07%-37.63%-21.70% 9.81B
-2.07%+2.93%+416.85%+35.57% 8.77B
-0.15%-6.14%-28.85% - 6.79B
+0.04%-0.28%+91.81%+54.09% 6.57B
-1.42%-2.98%-29.46%-20.49% 5.75B
-0.84%-4.33%-9.96%-20.90% 4.26B
-2.77%-4.25%+63.66%+79.79% 4.08B
-0.53%-2.70%-23.88%-30.15% 2.73B
Average -0.52%-1.12%+62.27%+54.49% 7.07B
Weighted average by Cap. -0.86%-0.59%+108.19%+136.82%

Financials

2024 2025
Net sales 10.51B 7.85M 6.75M 6.36M 5.79M 10.84M 747M 10.88M 75.35M 29.12M 380M 29.46M 28.82M 1.21B 15.12B 11.28M 9.71M 9.14M 8.33M 15.59M 1.07B 15.65M 108M 41.88M 547M 42.37M 41.45M 1.73B
Net income 2.44B 1.82M 1.57M 1.48M 1.35M 2.52M 173M 2.53M 17.5M 6.76M 88.34M 6.84M 6.69M 280M 4.47B 3.34M 2.87M 2.7M 2.46M 4.61M 318M 4.63M 32.04M 12.38M 162M 12.53M 12.26M 512M
Net Debt -13.23B -9.88M -8.5M -8M -7.29M -13.64M -940M -13.7M -94.84M -36.65M -479M -37.08M -36.28M -1.52B -13.38B -9.98M -8.59M -8.09M -7.37M -13.79M -950M -13.85M -95.88M -37.06M -484M -37.49M -36.68M -1.53B
Logo Protia Inc.
Protia Inc is a Korea-based company mainly engaged in the research and development of in vitro diagnostic medical devices and diagnostic reagents. The Company mainly produces allergy diagnostic reagents, allergy diagnostic equipment, point-of-care diagnosis products (POCT), among others. In addition, the Company is engaged in provision of protein related analysis services.
Employees
-
Date Price Change Volume
09/09/26 ₩5,170.00 +2.99% 13,738
08/09/26 ₩5,020.00 -0.59% 14,212
07/09/26 ₩5,050.00 +1.00% 128,228
04/09/26 ₩5,000.00 -4.58% 44,003
03/09/26 ₩5,240.00 -0.57% 15,042
  1. Stock Market
  2. Stocks
  3. A303360 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!